Recruiting

Genetic Research

Sponsor:

Boston Children's Hospital

Code:

NCT02743845

Conditions

Undiagnosed Conditions

Rare Disorders

Orphan Diseases

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The Gene Discovery Core at The Manton Center for Orphan Disease Research based at Boston Children's Hospital studies families with rare, poorly understood or undiagnosed, but suspected genetic conditions. The primary goal of the research is to better understand the genes and proteins (gene products) involved in rare diseases. The researchers hope that our studies will allow for improved diagnosis and treatment of individuals with rare disease in the future. Individuals with any rare/undiagnosed condition are eligible to enroll.

Enrollment includes:

  • Providing DNA and tissue samples (when available)
  • Access to participants' medical records
  • Access to genomic data (when available)

Samples are used for genetic analysis (primarily exome and genome sequencing or reanalysis) to identify the genetic cause for the individual's illness. Individual research results are returned to families through their health care provider after confirmation in a clinical lab. If a cause is identified, that can be reported back to the family through their health care provider and the study's genetic counselor. When possible, the investigators also collect samples from parents and full-siblings as well as any other affected family members.

Conditions

Undiagnosed Conditions

Rare Disorders

Orphan Diseases

Study ID

NCT02743845

Start date

Feb, 2010

Status verified date

Mar, 2026

Completion date

Dec, 2030

Anticipated

Primary completion date

Dec, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Having a known or uncertain rare diagnosis which may have a poorly understood genetic component and/or be a relative to a person with such a diagnosis

Exclusion Criteria:

  • Not having such a diagnosis and/or not being related to such an individual

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Identification of rare or novel disease-causing genetic variants for a participant's disorder [ Time Frame: 1-10 years ]
  • Characterization of clinical features of novel and rare disorders using Human Phenotype Ontology (HPO) terms [ Time Frame: 1-10 years ]

Central Contacts and Locations

Central contacts

Locations

Boston Children's Hospital

Recruiting

Boston, Massachusetts, United States, 02115

Contacts

More Information

Sponsor

Boston Children's Hospital

Last update posted

Mar 25, 2026

Last verified

Mar, 2026

Keywords

  • Rare
  • Undiagnosed
  • Orphan Disease
  • Genomic Sequencing

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-29. This information was provided to ClinicalTrials.gov by Boston Children's Hospital on 2026-03-25. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.